Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
16.12
+0.12 (0.75%)
At close: Aug 14, 2026, 4:00 PM EDT
15.80
-0.32 (-1.99%)
After-hours: Aug 14, 2026, 7:56 PM EDT
Janux Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 27.77 | 52.33 | 430.61 | 19.21 | 51.43 | 35.58 |
Short-Term Investments | 943.15 | 914.23 | 594.57 | 324.82 | 275.59 | 339.38 |
Cash & Short-Term Investments | 970.91 | 966.57 | 1,025 | 344.03 | 327.02 | 374.97 |
Cash Growth | -2.52% | -5.72% | 197.99% | 5.20% | -12.79% | 4699.24% |
Accounts Receivable | 0.15 | - | - | - | - | - |
Other Receivables | 6.18 | 6.43 | 5.38 | 2.16 | 0.7 | 0.2 |
Receivables | 6.33 | 6.43 | 5.38 | 2.16 | 0.7 | 0.2 |
Prepaid Expenses | 6.1 | 2.89 | 3.11 | 3.05 | 4.72 | 1.85 |
Total Current Assets | 983.34 | 975.89 | 1,034 | 349.24 | 332.44 | 377.02 |
Property, Plant & Equipment | 20.59 | 22.25 | 24.15 | 27.84 | 29.37 | 1.6 |
Other Long-Term Assets | 3.73 | 3.42 | 3.7 | 3.33 | 2.21 | 1.21 |
Total Assets | 1,008 | 1,002 | 1,062 | 380.41 | 364.01 | 379.82 |
Accounts Payable | 3.02 | 4.97 | 4.03 | 2.42 | 2.16 | 2.46 |
Accrued Expenses | 19.51 | 17.63 | 11.68 | 7.39 | 8.18 | 3.78 |
Current Portion of Leases | 2.55 | 2.39 | 1.75 | 1.52 | 0.76 | 0.19 |
Current Unearned Revenue | 35.07 | - | - | 1.71 | 5.41 | 5.16 |
Other Current Liabilities | - | - | - | - | - | 1.2 |
Total Current Liabilities | 60.15 | 25 | 17.46 | 13.03 | 16.51 | 12.8 |
Long-Term Leases | 18.44 | 19.75 | 21.28 | 23.03 | 24.54 | - |
Long-Term Unearned Revenue | 1.08 | - | - | - | 2.22 | 0.7 |
Total Liabilities | 79.67 | 44.74 | 38.74 | 36.06 | 43.27 | 13.5 |
Common Stock | 0.06 | 0.06 | 0.06 | 0.05 | 0.04 | 0.04 |
Additional Paid-In Capital | 1,328 | 1,304 | 1,258 | 512.4 | 432.7 | 413.97 |
Retained Earnings | -397.72 | -351.38 | -237.76 | -168.76 | -110.47 | -47.41 |
Comprehensive Income & Other | -2.31 | 4.32 | 2.16 | 0.67 | -1.54 | -0.27 |
Total Common Equity | 927.98 | 956.82 | 1,023 | 344.35 | 320.74 | 366.33 |
Shareholders' Equity | 927.98 | 956.82 | 1,023 | 344.35 | 320.74 | 366.33 |
Total Liabilities & Equity | 1,008 | 1,002 | 1,062 | 380.41 | 364.01 | 379.82 |
Total Debt | 20.99 | 22.14 | 23.03 | 24.54 | 25.31 | 0.19 |
Net Cash (Debt) | 949.92 | 944.43 | 1,002 | 319.49 | 301.71 | 374.77 |
Net Cash Growth | -2.45% | -5.76% | 213.68% | 5.89% | -19.50% | 4696.76% |
Net Cash Per Share | 15.21 | 15.24 | 18.64 | 7.26 | 7.28 | 15.93 |
Filing Date Shares Outstanding | 61.14 | 60.83 | 59.11 | 51.65 | 41.76 | 41.24 |
Total Common Shares Outstanding | 61.08 | 60.38 | 59.06 | 46.24 | 41.62 | 41.24 |
Working Capital | 923.19 | 950.89 | 1,016 | 336.21 | 315.93 | 364.22 |
Book Value Per Share | 15.19 | 15.85 | 17.32 | 7.45 | 7.71 | 8.88 |
Tangible Book Value | 927.98 | 956.82 | 1,023 | 344.35 | 320.74 | 366.33 |
Tangible Book Value Per Share | 15.19 | 15.85 | 17.32 | 7.45 | 7.71 | 8.88 |
Machinery | 11.08 | 10.82 | 9.81 | 9.87 | 7.91 | 1.4 |
Construction In Progress | - | - | - | - | - | 0.14 |